Growth factor receptor-bound protein 2 is an adaptor molecule that mediates B-cell receptor (BCR) signaling pathways, but the expression of
growth factor receptor-bound protein 2 in
lymphoma tissues has not been reported. We sought to characterize
growth factor receptor-bound protein 2 protein expression in reactive tonsillar tissues and
lymphoma tissues obtained from diagnostic biopsies of classical
Hodgkin lymphoma, primary mediastinal large
B-cell lymphoma,
diffuse large B-cell lymphoma, nodular lymphocyte predominant
Hodgkin lymphoma, and 20 low-grade
B-cell lymphomas.
Growth factor receptor-bound protein 2 expression was assessed in tissues by immunohistochemistry and in
lymphoma cell lines by immunoblotting. In reactive lymphoid tissues,
growth factor receptor-bound protein 2 was expressed in the cytoplasm of B-cells and histiocytes but not T-cells. Strong, cytoplasmic
growth factor receptor-bound protein 2 expression was seen in the neoplastic cells of
follicular lymphoma,
chronic lymphocytic leukemia/
small lymphocytic lymphoma, splenic marginal zone
lymphoma, primary mediastinal large
B-cell lymphoma,
diffuse large B-cell lymphoma, and nodular lymphocyte predominant
Hodgkin lymphoma. In contrast, only 10% of the classical Hodgkin
lymphomas showed
growth factor receptor-bound protein 2 expression in the neoplastic cells.
Growth factor receptor-bound protein 2 protein expression was detected by Western blotting in all
lymphoma cell lines tested with higher levels in primary mediastinal large
B-cell lymphoma compared with classical
Hodgkin lymphoma cell lines. These findings support a role for
growth factor receptor-bound protein 2 in the diagnostically challenging workup of classical
Hodgkin lymphoma versus primary mediastinal large
B-cell lymphoma and warrant further studies to evaluate the
biologic significance of
growth factor receptor-bound protein 2 in the pathogenesis of classical
Hodgkin lymphoma.